Fortitude Advisory Group’s Q32 Bio QTTB Stock Holding History

Fortitude Advisory Group’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25	Closed	-$1K	–	1343
2022 Q1	$1K	Buy	25 +13	+108%	+$807	﹤0.01%	1478
2021 Q4	$1K	Buy	+12	New	+$1.17K	﹤0.01%	1516

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fortitude Advisory Group's QTTB Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 25 shares — an estimated $1K sold.

Fortitude Advisory Group first reported a position in QTTB in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

Fortitude Advisory Group reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
Fortitude Advisory Group sold 25 Q32 Bio shares in Q2 2022, an estimated $1K.
Fortitude Advisory Group first reported a position in Q32 Bio in Q4 2021 and held it in 2 quarters.
Fortitude Advisory Group's Q32 Bio position peaked at $1K in Q1 2022.
87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.